AveXis' P2P Acquisition

AveXis raised a round of funding on April 09, 2018. Investors include Novartis.

AveXis is a clinical-stage gene therapy company developing treatments for rare and life-threatening neurological genetic diseases. The company's initial product candidate, scAAV9.CB.SMN, is in an ongo…

Articles about AveXis' P2P Acquisition: